Progress with palbociclib in breast cancer: latest evidence and clinical considerations

od Rocca, Andrea, Schirone, Alessio, Maltoni, Roberta, Bravaccini, Sara, Cecconetto, Lorenzo, Farolfi, Alberto, Bronte, Giuseppe, Andreis, Daniele
izdano v Ther Adv Med Oncol (2016)

Impressive long-term response with chemo-endocrine therapy in a premenopausal patient with metastatic breast cancer: A case report

od Maltoni, Roberta, Palleschi, Michela, Gallerani, Giulia, Bravaccini, Sara, Cecconetto, Lorenzo, Melegari, Elisabetta, Altini, Mattia, Rocca, Andrea
izdano v Medicine (Baltimore) (2020)

Can cyclin-dependent kinase 4/6 inhibitors convert inoperable breast cancer relapse to operability? A case report

od Palleschi, Michela, Maltoni, Roberta, Barzotti, Eleonora, Melegari, Elisabetta, Curcio, Annalisa, Cecconetto, Lorenzo, Sarti, Samanta, Manunta, Silvia, Rocca, Andrea
izdano v World J Clin Cases (2020)

Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review

od FAROLFI, ALBERTO, FERRARIO, CRISTIANO, AQUILINA, MICHELE, CECCONETTO, LORENZO, TARTAGLIA, ANDREAS, IBRAHIM, TONI, SERRA, LUIGI, OBOLDI, DEVIL, NIZZOLI, MAURIZIO, ROCCA, ANDREA
izdano v Oncol Lett (2015)

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

od Zoli Wainer, Zumaglini Federica, Oliverio Giovanni, Pasquini Enzo, Dazzi Claudio, Dall'Agata Monia, Cecconetto Lorenzo, Passardi Alessandro, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino
Izdano 2008-10-01

Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer

od Passardi, Alessandro, Cecconetto, Lorenzo, Dall'Agata, Monia, Dazzi, Claudio, Pasquini, Enzo, Oliverio, Giovanni, Zumaglini, Federica, Zoli, Wainer, Nanni, Oriana, Milandri, Carlo, Frassineti, Giovanni Luca, Amadori, Dino
Izdano 2008

RANKL: A promising circulating marker for bone metastasis response

od Ibrahim, Toni, Ricci, Marianna, Scarpi, Emanuela, Bongiovanni, Alberto, Ricci, Rossana, Riva, Nada, Liverani, Chiara, De Vita, Alessandro, La Manna, Federico, Oboldi, Devil, Serra, Patrizia, Foca, Flavia, Cecconetto, Lorenzo, Amadori, Dino, Mercatali, Laura
izdano v Oncol Lett (2016)

Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer

od Rocca, Andrea, Cecconetto, Lorenzo, Passardi, Alessandro, Melegari, Elisabetta, Andreis, Daniele, Monti, Manuela, Maltoni, Roberta, Sarti, Samanta, Pietri, Elisabetta, Schirone, Alessio, Fabbri, Francesco, Donati, Caterina, Nanni, Oriana, Fedeli, Anna, Faedi, Marina, Amadori, Dino
izdano v Cancer Chemother Pharmacol (2017)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

od Bronte, Giuseppe, Bravaccini, Sara, Ravaioli, Sara, Puccetti, Maurizio, Scarpi, Emanuela, Andreis, Daniele, Tumedei, Maria Maddalena, Sarti, Samanta, Cecconetto, Lorenzo, Pietri, Elisabetta, De Simone, Valeria, Maltoni, Roberta, Bonafè, Massimiliano, Amadori, Dino, Rocca, Andrea
izdano v Transl Oncol (2018)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

od Bronte, Giuseppe, Rocca, Andrea, Ravaioli, Sara, Puccetti, Maurizio, Tumedei, Maria Maddalena, Scarpi, Emanuela, Andreis, Daniele, Maltoni, Roberta, Sarti, Samanta, Cecconetto, Lorenzo, Fedeli, Anna, Pietri, Elisabetta, De Simone, Valeria, Asioli, Silvia, Amadori, Dino, Bravaccini, Sara
izdano v BMC Cancer (2018)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

od Palleschi, Michela, Maltoni, Roberta, Ravaioli, Sara, Vagheggini, Alessandro, Mannozzi, Francesca, Fanini, Francesca, Pirini, Francesca, Tumedei, Maria Maddalena, Barzotti, Eleonora, Cecconetto, Lorenzo, Sarti, Samanta, Manunta, Silvia, Possanzini, Paola, Fedeli, Anna, Curcio, Annalisa, Altini, Mattia, De Giorgi, Ugo, Rocca, Andrea, Bravaccini, Sara
izdano v Diagnostics (Basel) (2020)